Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Parkinson'S Disease|February 21, 2015
Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's DiseaseReinika Mitra, Patrik Aronsson, Michael Winder, et al.
Autonomic Neuroscience : Basic & Clinical|February 20, 2025
Monotherapy with tolterodine or mirabegron is insufficient for ameliorating cyclophosphamide-induced bladder overactivity in ratsHåvard Fjelltveit, Thomas Carlsson, Fernando Perez, et al.
Clinical and Experimental Pharmacology & Physiology|December 18, 2013
In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the ratUday K Killi, Vladimir Wsol, Ondrej Soukup, et al.
Frontiers in Physiology|September 21, 2023
Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxidePatrik Aronsson, Johanna Stenqvist, Ena Ferizovic, et al.
Biomed Research International|July 2, 2014
Inhibition of nitric oxide synthase prevents muscarinic and purinergic functional changes and development of cyclophosphamide-induced cystitis in the ratPatrik Aronsson, Renata Vesela, Martin Johnsson, et al.
Neurourology and Urodynamics|November 2, 2023
New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023Anthony Kanai, Basu Chakrabarty, Michael Winder, et al.
Current Neuropharmacology|June 10, 2016
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological TreatmentOndrej Soukup, Michael Winder, Uday Kumar Killi, et al.
Neurourology and Urodynamics|October 30, 2023
Nitric oxide signaling pathways in the normal and pathological bladder: Do they provide new pharmacological pathways?-ICI-RS 2023Basu Chakrabarty, Michael Winder, Anthony J Kanai, et al.
Gastroenterology Research and Practice|February 6, 2023
6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson's DiseaseMaria Del Pilar Murillo, Ebba Johansson, Victoria Bryntesson, et al.
European Journal of Pharmacology|June 1, 2022
Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitisOzgu Aydogdu, Fernando Perez, Patrik Aronsson, et al.
Pageof 4